𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Long-term efficacy and safety of botulinum toxin type A (Dysport) in cervical dystonia

✍ Scribed by Daniel Truong; Matthew Brodsky; Mark Lew; Allison Brashear; Joseph Jankovic; Eric Molho; Olga Orlova; Sofia Timerbaeva

Book ID
116820769
Publisher
Elsevier Science
Year
2010
Tongue
English
Weight
228 KB
Volume
16
Category
Article
ISSN
1353-8020

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Long-term safety, efficacy, dosing, and
Long-term safety, efficacy, dosing, and development of resistance with botulinum toxin type B in cervical dystonia
✍ Brian Berman; Lauren Seeberger; Rajeev Kumar πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 64 KB

## Abstract Short‐term studies of cervical dystonia (CD) have demonstrated botulinum toxin type B (Bot B) to be safe and efficacious at doses of 5,000 to 10,000 units, but few long‐term studies have been published and the safety and efficacy of higher doses has not been established. Additionally, t

Efficacy and safety of botulinum type A
Efficacy and safety of botulinum type A toxin (Dysport) in cervical dystonia: Results of the first US randomized, double-blind, placebo-controlled study
✍ Daniel Truong; Drake D. Duane; Joseph Jankovic; Carlos Singer; Lauren C. Seeberg πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 89 KB

## Abstract Botulinum toxin type A (Dysport) has been shown in European studies to be a safe and effective treatment for cervical dystonia. This multicenter, double‐blind, randomized, controlled trial assessed the safety and efficacy of Dysport in cervical dystonia patients in the United States. Ei